In new independent research reports released early this morning,
Market Source Research released its latest key findings for all
current investors, traders, and shareholders of Xilinx, Inc.
(NASDAQ:XLNX), J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT),
Southern Company (NYSE:SO), FirstEnergy Corporation (NYSE:FE), AMAG
Pharmaceuticals, Inc. (NASDAQ:AMAG), and Galectin Therapeutics Inc.
(NASDAQ:GALT), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified
analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
XLNX DOWNLOAD:
http://MarketSourceResearch.com/register/?so=XLNX JBHT DOWNLOAD:
http://MarketSourceResearch.com/register/?so=JBHT SO DOWNLOAD:
http://MarketSourceResearch.com/register/?so=SO FE DOWNLOAD:
http://MarketSourceResearch.com/register/?so=FE AMAG DOWNLOAD:
http://MarketSourceResearch.com/register/?so=AMAG GALT DOWNLOAD:
http://MarketSourceResearch.com/register/?so=GALT
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Market Source
Research, available for free download at the links above, examine
Xilinx, Inc. (NASDAQ:XLNX), J.B. Hunt Transport Services, Inc.
(NASDAQ:JBHT), Southern Company (NYSE:SO), FirstEnergy Corporation
(NYSE:FE), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), and Galectin
Therapeutics Inc. (NASDAQ:GALT) on a fundamental level and outlines
the overall demand for their products and services in addition to
an in-depth review of the business strategy, management discussion,
and overall direction going forward. Several excerpts from the
recently released reports are available to today's readers
below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. All information in
this release was accessed November 28th, 2017. Percentage
calculations are performed after rounding. All amounts in millions
(MM), except per share amounts.
-----------------------------------------
Xilinx, Inc. (XLNX) REPORT OVERVIEW
Xilinx's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Xilinx reported revenue of $619.50MM vs
$579.21MM (up 6.96%) and basic earnings per share $0.68 vs $0.65
(up 4.62%). For the twelve months ended March 31st, 2017 vs March
31st, 2016, Xilinx reported revenue of $2,349.33MM vs $2,213.88MM
(up 6.12%) and basic earnings per share $2.47 vs $2.14 (up 15.42%).
Xilinx is expected to report earnings on January 24th, 2018. The
report will be for the fiscal period ending December 31st, 2017.
The reported EPS for the same quarter last year was $0.52. The
estimated EPS forecast for the next fiscal year is $2.85 and is
expected to report on April 25th, 2018.
To read the full Xilinx, Inc. (XLNX) report, download it here:
http://MarketSourceResearch.com/register/?so=XLNX
-----------------------------------------
J.B. Hunt Transport Services, Inc. (JBHT) REPORT
OVERVIEW
J.B. Hunt Transport Services' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, J.B. Hunt Transport Services reported
revenue of $1,843.33MM vs $1,690.66MM (up 9.03%) and basic earnings
per share $0.92 vs $0.97 (down 5.15%). For the twelve months ended
December 31st, 2016 vs December 31st, 2015, J.B. Hunt Transport
Services reported revenue of $6,555.46MM vs $6,187.65MM (up 5.94%)
and basic earnings per share $3.84 vs $3.69 (up 4.07%). J.B. Hunt
Transport Services is expected to report earnings on January 18th,
2018. The report will be for the fiscal period ending December
31st, 2017. The reported EPS for the same quarter last year was
$0.97. The estimated EPS forecast for the next fiscal year is $4.42
and is expected to report on January 18th, 2018.
To read the full J.B. Hunt Transport Services, Inc. (JBHT)
report, download it here:
http://MarketSourceResearch.com/register/?so=JBHT
-----------------------------------------
Southern Company (SO) REPORT OVERVIEW
Southern's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Southern reported revenue of $6,201.00MM
vs $6,264.00MM (down 1.01%) and basic earnings per share $1.07 vs
$1.18 (down 9.32%). For the twelve months ended December 31st, 2016
vs December 31st, 2015, Southern reported revenue of $19,896.00MM
vs $17,489.00MM (up 13.76%) and basic earnings per share $2.57 vs
$2.60 (down 1.15%). Southern is expected to report earnings on
February 28th, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter
last year was $0.24. The estimated EPS forecast for the next fiscal
year is $3.02 and is expected to report on February 28th, 2018.
To read the full Southern Company (SO) report, download it here:
http://MarketSourceResearch.com/register/?so=SO
-----------------------------------------
FirstEnergy Corporation (FE) REPORT
OVERVIEW
FirstEnergy's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, FirstEnergy reported revenue of
$3,714.00MM vs $3,917.00MM (down 5.18%) and basic earnings per
share $0.89 vs $0.89 (unchanged). For the twelve months ended
December 31st, 2016 vs December 31st, 2015, FirstEnergy reported
revenue of $14,562.00MM vs $15,026.00MM (down 3.09%) and basic
earnings per share -$14.49 vs $1.37. FirstEnergy is expected to
report earnings on February 20th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $0.38. The estimated EPS forecast for
the next fiscal year is $2.51 and is expected to report on February
20th, 2018.
To read the full FirstEnergy Corporation (FE) report, download
it here:
http://MarketSourceResearch.com/register/?so=FE
-----------------------------------------
AMAG Pharmaceuticals, Inc. (AMAG) REPORT
OVERVIEW
AMAG Pharmaceuticals' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, AMAG Pharmaceuticals reported revenue of
$153.74MM vs $143.78MM (up 6.93%) and basic earnings per share
-$4.31 vs $0.47. For the twelve months ended December 31st, 2016 vs
December 31st, 2015, AMAG Pharmaceuticals reported revenue of
$532.09MM vs $418.28MM (up 27.21%) and basic earnings per share
-$0.07 vs $1.04. AMAG Pharmaceuticals is expected to report
earnings on February 13th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was -$0.31. The estimated EPS forecast for the
next fiscal year is -$1.95 and is expected to report on February
13th, 2018.
To read the full AMAG Pharmaceuticals, Inc. (AMAG) report,
download it here:
http://MarketSourceResearch.com/register/?so=AMAG
-----------------------------------------
Galectin Therapeutics Inc. (GALT) REPORT
OVERVIEW
Galectin Therapeutics' Recent Financial
Performance
Galectin Therapeutics is expected to report
earnings on March 27th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was -$0.13. The estimated EPS forecast for the
next fiscal year is -$0.58 and is expected to report on March 27th,
2018.
To read the full Galectin Therapeutics Inc. (GALT) report,
download it here:
http://MarketSourceResearch.com/register/?so=GALT
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research
reports that helps serious investors, registered brokers,
professional traders, and personal investment advisers find
reliable information in today's markets. Market Source Research's
team is comprised of financial professionals, many of which hold
Chartered Financial Analyst® (CFA®) designations and FINRA®
BrokerCheck® certifications. Whether identifying emerging trends,
or discovering new opportunity, the team at Market Source Research
is dedicated to providing accurate, informative, and objective
content that's ahead of the curve. With insights on individual
companies as well as sectors, readers get the industry's best
available combination of big-picture perspective as well as
granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit
staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Market Source Research's roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Market Source
Research have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Market Source Research's
Compliance department by Phone, at +1 (704) 343-6361, or by E-mail
at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Market Source
Research, Market Source Research members, and/or Market Source
Research affiliates are not responsible for any gains or losses
that result from the opinions expressed. Market Source Research
makes no representations as to the completeness, accuracy, or
timeliness of the material provided and all materials are subject
to change without notice. Market Source Research has not been
compensated for the publication of this press release by any of the
above mentioned companies. Market Source Research is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Hugo Moreau, Media Department
Office: +1 (704) 343-6361 E-mail:
media@MarketSourceResearch.com
© 2017 Market Source Research. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From Apr 2024 to May 2024
AMAG Pharmaceuticals (NASDAQ:AMAG)
Historical Stock Chart
From May 2023 to May 2024